Hyperhomocysteinemia (HHcy, total homocysteine concentrations> 15 μmol/L) has been
associated with increased risk of many diseases. A systematic review was performed to …

Homocysteine (Hcy) is a sulfur-containing amino acid generated during methionine
metabolism, accumulation of which may be caused by genetic defects or the deficit of …

Background It has been documented that patients with metabolic syndrome (MS) and
vascular complications have higher homocysteine levels. Hyperhomocysteinemia correlates …

To analyze weight gain, metabolic hormones, and homocysteine (Hcys) levels in children
and adolescents on antipsychotics (AP) during a year-long follow-up. 117 patients, AP-naïve …

Abstract Background Metabolic syndrome (MetS) is a clinical condition potentially promoting
the development of atherosclerotic disease. To date, the clinical impact of elevated serum …

Biomarkers of the metabolic syndrome are divided into four subgroups. Although dividing
them in groups has some limitations, it can be used to draw some conclusions. In a first part …

Metabolic syndrome (MS) has a multifactorial and not yet fully clarified origin. Insulin
resistance is a key element that connects all the accepted components of MS (obesity …

Patients with both hypertension and hyperhomocysteinemia, termed H‐type hypertension,
have a high risk for cardiocerebrovascular diseases. However, little is known about the …

Background: Considerable studies showed associations between chronic obstructive
pulmonary disease (COPD) and cardiovascular disease (CVD), we evaluated the role of …

Considering the significant role of plasma homocysteine in physiological processes, two
ensembles (F 465–Cu 2+ and F 508–Cu 2+) were constructed based on a BODIPY (4, 4 …